The case of Cushing's disease imaging by SPECT examination without manifestation of adenoma in MRI examination

Nuclear Medicine Review

Volumn 8, Issue 2, 2005, Pages 137-139

  Gierach, Marcin ^a   Pufal, Joanna ^a   Pilecki, Stanislaw ^a   Junik, Roman ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Cushing disease; MRI; SPECT

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; ARTICLE; CASE REPORT; CUSHING DISEASE; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSTIC IMAGING; DRUG ACCUMULATION; HUMAN; HYPOPHYSIS ADENOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR LOCALIZATION;

ADENOMA; ADULT; CUSHING SYNDROME; FALSE NEGATIVE REACTIONS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PITUITARY NEOPLASMS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 30944450452     PISSN: 15069680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Arnaldi G, Angeli A, Atkinson A, Bertagna X, Cavagnini F, Chrousos G et al. Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 2003; 88: 5593-5602.
2. Lastoria S, Colao A, Vergara E, Ferone D, Varrella P, Merola B et al. Technetium-99m pentavalent dimercaptosuccinic amid imaging in patients with pituitary adenomas. Eur J Endocrinol 1995; 133: 38-47.
3. Lundin P, Nyman R, Burman P, Lundberg PO, Muhr C. MRI of pituitary macroadenomas with reference to hormonal activity. Neuroradiology 1992; 34: 43-51.
4. Lundin P, Bergtrom K, Thuomas KA, Lundberg PO, Muhr C. Comparison of MR imaging and CT in pituitary macroadenomas. Acta Radiol 1991; 32: 189-196.
5. Semple PL, Laws Jr ER. Complications in a contemporary series of patients who underwent transsphenoidal surgery for Cushing's di-sease. J Neurosurg 1999; 91: 175-179.
6. Ludecke DK, Flitsch J, Knappe UJ. Cushing's disease: a surgical view. J Neuro-Oncol 2001; 54: 151.
7. O'Tauma A, Treves ST, Larar JN et al. Thalium-201 versus Technetium-99m-MIBI SPECT in evaluation of childhood brain tumors: a within-subject comparison. J Nucl Med 1993; 34: 1045-1051.
8. Newton DR, Dillon WP, Normal D. Gd-DTPA-enhanced MR imaging of pituitary adenomas. Am J Nucl Res 1989; 10: 949-954.
9. Kulkarni MV, Lee KF, McArdle CB. 1.5 T MR imaging of pituitary microadenomas: technical considerations and CT correlations. Am J Nucl Res 1989; 9: 5-11.
10. Kucharczyk W, Davis DO, Kely WM. Pituitary adenomas: high resolution MR imaging at 1.5 T. Radiology 1986; 161: 761-765.
11. Bagni B, Pinna L, Tamarozzi R, Cattaruzzi E, Marzola MC, Bagni I et al. SPECT imaging of intracranial tumours with 99mTc-sestamibi. Nucl Med Comm 1995; 16: 258-264.
12. Piwnica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutylisonitrile) technetium in cultured chick myocardial cells: mitochondrial and plasma membrane potential dependence. Circulation 1990; 82: 1826-1838.